Takeshi Miyake
Overview
Explore the profile of Takeshi Miyake including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
232
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kawanishi Y, Miyake T, Yamanaka M
J Med Invest
. 2024 Oct;
71(3.4):219-224.
PMID: 39462555
Objectives: This study aimed to clarify the cumulative effectiveness of microsurgical penile revascularization over time and factors that affect surgical outcomes. Subjects And Methods: This study analyzed 114 men with...
2.
Kawanishi Y, Miyake T, Yamanaka M
Arab J Urol
. 2024 Oct;
22(4):212-218.
PMID: 39355789
Objective: Chronic ischemia-related cavernous dysfunction is considered irreversible. However, in certain patients, cavernous function appears to recover with penile revascularization. In this study, we investigated a potential cavernous dysfunction reversibility...
3.
Moromizato M, Miyake T, Masuda T, Kimura T, Kimura K
Phys Rev Lett
. 2024 Sep;
133(8):086701.
PMID: 39241717
We visualize antiferromagnetic domains in a representative quasi-one-dimensional S=1/2 quantum antiferromagnet, BaCu_{2}Si_{2}O_{7}, using nonreciprocal directional dichroism, which differentiates the optical absorption of a pair of antiferromagnetic domains. Opposite antiferromagnetic domains,...
4.
Munakata W, Izutsu K, Mishima Y, Nagai H, Ishihara Y, Suzumiya J, et al.
Jpn J Clin Oncol
. 2023 Jul;
53(10):912-921.
PMID: 37486002
Objective: This dose-escalation part of an ongoing Phase I study assessed the tolerability, safety and pharmacokinetics of mosunetuzumab in Japanese patients with relapsed/refractory B-cell non-Hodgkin lymphoma (NHL). Methods: Mosunetuzumab was...
5.
Miyake T, Kimoto E, Luo L, Mathialagan S, Horlbogen L, Ramanathan R, et al.
Clin Pharmacol Ther
. 2020 Sep;
109(2):507-516.
PMID: 32866300
Endogenous biomarkers are emerging to advance clinical drug-drug interaction (DDI) risk assessment in drug development. Twelve healthy subjects received a multidrug and toxin exclusion protein (MATE) inhibitor (pyrimethamine, 10, 25,...
6.
Miyake T, Mizuno T, Takehara I, Mochizuki T, Kimura M, Matsuki S, et al.
Drug Metab Dispos
. 2019 Sep;
47(11):1270-1280.
PMID: 31511257
Endogenous substrates are emerging biomarkers for drug transporters, which serve as surrogate probes in drug-drug interaction (DDI) studies. In this study, the results of metabolome analysis using wild-type and Oct1/2...
7.
Yokomori T, Tozaki T, Mita H, Miyake T, Kakoi H, Kobayashi Y, et al.
BMC Res Notes
. 2019 Jun;
12(1):346.
PMID: 31215455
Objective: According to oral traditions of horse caretakers and trainers, the differences in the position and number of facial hair whorls may be associated with temperamental traits. Elucidating genetic background...
8.
Tozaki T, Miyake T, Kikuchi M, Kakoi H, Hirota K, Kusano K, et al.
J Anim Breed Genet
. 2019 Feb;
136(3):199-204.
PMID: 30790380
Thoroughbred racehorses are produced by mating small numbers of Arabian stallions and native British mares, and have been improved by selection of horseracing performance for about 300 years. While these...
9.
Ramadan S, Miyake T, Yamaura J, Inoue-Murayama M
PLoS One
. 2018 May;
13(5):e0195121.
PMID: 29775483
Pigeon racing is a popular sport worldwide. Pigeons are under continuous selection to improve speed, spatial orientation, and endurance during long flights. However, numerous genetic and non-genetic factors affect survivability...
10.
Sasaki Y, Shiozaki K, Miyake T, Izumi K, Kishimoto T, Yamanaka M, et al.
Nihon Hinyokika Gakkai Zasshi
. 2018 Apr;
108(2):101-105.
PMID: 29669972
In the present report, we describe a patient with microcystic variant of urothelial carcinoma in urinary bladder. In March 2016, a 71-year-old man presented with bladder tumors found incidentally by...